Skip to main content

Table 1 PADI4 haplotype combinations in Caucasian individuals

From: Detailed analysis of the variability of peptidylarginine deiminase type 4 in German patients with rheumatoid arthritis: a case–control study

Haplotype A

Haplotype B

 

Haplotype 1

Haplotype 1B

Haplotype 2/3

Haplotype 4

Haplotype 1

    

   Controls

35 (34.3%)

5 (4.9%)

35 (34.3%)

9 (8.8%)*

   Patients

25 (24.5%)

1 (1%)

31 (30.4%)

20 (19.6%)*

Haplotype 1B

    

   Controls

0

0

1 (1%)

0

   Patients

0

0

0

0

Haplotype 2/3

    

   Controls

0

0

12 (11.8%)

3 (2.9%)

   Patients

0

0

17 (16.7%)

6 (5.9%)

Haplotype 4

    

   Controls

0

0

0

2 (2%)

   Patients

0

0

0

2 (2%)

  1. Frequencies of different PADI4 haplotype combinations in patients with rheumatoid arthritis (n = 102) and in healthy controls (n = 102) are presented. *P < 0.05 (Fisher's exact test).